Purposeful Focus. Global Impact.
Turning care into discovery, and discovery into care
Within this strategic plan, Mater Research will build a sustainable, high-performing research business by clearly articulating our focus areas, strengthening our reputation for research impact, increasing participation in research and clinical trials, and supporting the growth of our people and capabilities. We will be deliberate in how and where we invest, ambitiously expanding our commercial clinical trial activity to strengthen our financial health and position Mater Research for talent, partnerships, and growth at scale.
Our Strategic Plan
Refining our focus | Elevate to enable our purpose | Intentional investment and growth |
- Focus on clear flagship research areas to guide investment, attract partnerships, and align with national priorities:
- Women’s and babies’ health
- Cancer
- Brain health
- Inflammation modulation
- Mater Clinical Trials.
- Our key research approaches will include
- Genomics and multi-omics
- Models of care transformation
- Preclinical model innovation
- Diagnostic and treatment precision
- Drug target identification and validation
- Cell-based and immune-therapies
- Strengthen our reputation and brand to achieve national and international visibility
- Increase patient access to research and clinical trial participation, regardless of location
| - Strengthen our workforce culture to support attraction and retention of talent
- Embed research into clinical care at Mater and strengthen clinician-researcher integration
- Boost our research development capabilities (biobanking, biostatistics, grant development, consumer engagement)
- Adopt an inter-disciplinary approach to achieve bigger, bolder, collaborative funding bids
- Design creative service models to achieve efficiency in our operations
- Leverage and strengthen strategic partnerships, including to fill key capability gaps where internal investment is not justified, such as drug discovery
| - Grow our sustainable business model
- Pursue targeted commercial growth of clinical trials and establish a world class trials ecosystem
- Pursue growth in industry funding through contract and consultancy research
- Develop considered and proactive disinvestment approaches
- Modernise our digital and data platforms and capabilities
- Undertake targeted, ambitious recruitment in key research focus areas
- Directly contribute to Mater’s health system performance through targeted research support in response to clinical or operational challenges
|
